Cubist to Present at December Investor Conference

By: Cubist Pharmaceuticals, Inc. via Business Wire News Releases

Posted on December 03, 2012 at 09:48 AM EST

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23rd Annual Healthcare Conference in December 2012. Details are below.

			PRESENTER:			Steve Gilman, EVP and Chief Scientific Officer
			EVENT:			Oppenheimer 23rd Annual Healthcare Conference
			DATE:			Thursday, December 13, 2012
			TIME:			10:35 a.m. Eastern Time
			LOCATION:			The Waldorf Astoria, New York City
			WEBCAST:			Live audio with slide webcast can be accessed here.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.

Contacts:

Investors:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
Media:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com

Related Stocks:

Cubist Pharmaceuticals, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates